HOME >> MEDICINE >> NEWS
Research offers hope of new treatments for liver damage 'plague'

Millions of patients suffering from liver damage (cirrhosis) and failure may benefit from research by the Universities of Edinburgh and Southampton which may lead to new life-saving treatments. There is currently no cure for liver cirrhosis and a patient's only hope of survival is to receive a liver transplant.

The Edinburgh scientists from the University's Centre for Inflammation Research, in collaboration with colleagues from the University of Southampton and Cincinnati, USA have, for the first time, identified two separate populations of immune cells --macrophages--in the liver. One group of macrophages causes scarring to the liver, but the next wave of immune cells, produced only a few days later, change function to break down and reabsorb the scarring. These findings, published in the January edition of Journal of Clinical Investigation, will help doctors to understand the mechanisms by which the liver is damaged and repaired and may lead to future treatments.

Researcher Dr Jeremy Duffield explained: "The links between the immune system, inflammation and scarring in the liver have not been well understood, and this has hindered progress in finding ways to prevent and repair liver damage. Now that we have shown how the macrophages work, we aim to find out how to create, activate and de-activate these cells to make them repair, rather than damage, liver tissue."

He added: "Cirrhosis, commonly, but not always, caused by alcohol consumption, can lead to liver failure. At a time when outcomes for other diseases, such as cancers and heart trouble, have made dramatic gains, liver damage --described as the new plague of the 21st century --has yet to be understood and in turn, to become treatable. More women in the UK now die of liver failure than do of cancer of the cervix.

"There has been a fourfold increase in the number of men aged 45-54 dying of cirrhosis since 1970 and a threefold increase in women of the same age group. Liver fail
'"/>

Contact: Linda Menzies
Linda.Menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
5-Jan-2005


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research offers hope new treatments for liver damage plague

(Date:5/19/2013)... At a May 6th, 2013 meeting ... Physicians (NCAPIP), the Pacific Chronic Disease Coalition (PCDC), ... Disease Directors (NACDD), presented a newly published assessment ... non-communicable diseases (NCDs) in the U.S. Associated Pacific ... Hawaii Journal of Medicine and Public Health, highlights ...
(Date:5/19/2013)... 19 (HealthDay News) -- Although spring arrived late this ... allergy season will still be strong, according to a ... Dr. Richard Waguespack, clinical professor in the university,s ... in a robust summer allergy season. However, some simple ... wheezing and coughing, he added. "Tree pollen has ...
(Date:5/19/2013)... ─ Gourmands and foodies everywhere have long recognized ginger ... zing to both sweet and savory dishes; now, a ... of the spicy root also may have properties that ... of the study will be presented at the ATS ... a tightening of the bronchial tubes that carry air ...
(Date:5/19/2013)... MO (PRWEB) May 19, 2013 Healthcare ... May 19-22, 2013, at the Walt Disney World Swan ... trends in supply chain innovation, care delivery and healthcare ... different dynamic in all healthcare markets, with ... of the conversation,” said Todd Ebert, Amerinet president and ...
(Date:5/19/2013)... May 19, 2013 People in Minnesota have ... Altman Fitness is offering its 28 Day Fat Loss Formula. ... from the comfort of their own home. The product sells ... More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , ... leave their houses now, but after using the 28 Day ...
Breaking Medicine News(10 mins):Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Managing Seasonal Allergies 2Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2
(Date:5/16/2013)... and MECHELEN, Belgium , May ... AbbVie (NYSE: ABBV ) announced today an ... Crohn,s disease.  Galapagos will fund and complete a Phase ... facilitate rapid progression into Phase 3.  Upon successful completion ... pay Galapagos $50 million.  The terms of the collaboration ...
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)... 2013  Amgen (NASDAQ: AMGN ) will participate ... 21, 2013, at the Sheraton New York Times Square in ... a.m. Eastern Daylight Time. Joseph P. Miletich ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
Cached News: